Quercetin

Quercetin, a naturally occurring flavonoid found in various plants and fruits, has been the subject of numerous clinical trials investigating its potential therapeutic effects. These studies have explored quercetin’s role in treating a wide range of conditions, including gastroesophageal reflux disease (GERD), chronic obstructive pulmonary disease (COPD), coronary artery disease, post-operative pain, and even COVID-19. This article summarizes the key findings from recent clinical trials, highlighting the promising applications of quercetin in medical research.

Table of Contents

What is Quercetin?

Quercetin is a natural compound belonging to a group of plant pigments called flavonoids. It is one of the most abundant and active flavonoids found in many fruits, vegetables, and herbs. Quercetin is known for its potent antioxidant, anti-inflammatory, and antihistamine (antiallergic) properties[1].

Interestingly, quercetin has a rich history in scientific research. In 1937, Albert Szent-Gyorgyi received a Nobel Prize for discovering vitamin C and flavonoids, including quercetin. Initially, he named flavonoids “vitamin P” due to their effectiveness in reducing blood vessel permeability. However, this name was later abandoned when it was realized that these substances were not true vitamins[1].

Health Benefits of Quercetin

Quercetin offers a wide range of potential health benefits, including:

  • Antioxidant effects: Quercetin helps protect cells from damage caused by harmful molecules called free radicals[1].
  • Anti-inflammatory properties: It may help reduce inflammation throughout the body[1].
  • Cardiovascular health: Quercetin may improve blood vessel function and reduce the risk of heart disease[2].
  • Immune system support: It may enhance the body’s natural defense mechanisms[1].
  • Antihistamine effects: Quercetin may help alleviate allergy symptoms[1].

Medical Conditions Treated with Quercetin

Research suggests that quercetin may be beneficial in treating or managing various medical conditions:

  • Gastroesophageal Reflux Disease (GERD): Quercetin may help improve the barrier function of the esophagus, potentially reducing symptoms of GERD[3].
  • Chronic Obstructive Pulmonary Disease (COPD): Studies are investigating quercetin’s potential to reduce inflammation and oxidative stress in COPD patients[4].
  • Coronary Artery Disease: Quercetin may have protective effects on the cardiovascular system and is being studied for its potential benefits in patients with coronary artery disease[2].
  • Post-operative Pain: Research is exploring quercetin’s potential to reduce pain following cesarean section surgeries[5].
  • Mental Health Disorders: Quercetin is being investigated for its potential to address accelerated aging in individuals with depression or schizophrenia[6].
  • Oral Lichen Planus: Studies are examining quercetin’s effectiveness in treating this chronic inflammatory condition affecting the mouth[7].
  • COVID-19: Researchers are investigating quercetin’s potential antiviral and anti-inflammatory properties in the context of COVID-19 treatment[1].

Dosage and Administration

The dosage and administration of quercetin can vary depending on the specific condition being treated and the formulation used. In clinical trials, the following dosages have been studied:

  • For COPD: 500-2000 mg per day, taken orally[4].
  • For coronary artery disease: 500 mg per day, taken orally[2].
  • For post-operative pain: 500 mg taken orally 1 hour before surgery[5].
  • For COVID-19 treatment: Various dosages are being studied, typically ranging from 500-1000 mg per day[1].

It’s important to note that these dosages are based on clinical trials and may not represent recommended doses for general use. Always consult with a healthcare professional before starting any new supplement regimen.

Ongoing Research and Clinical Trials

Quercetin is the subject of numerous ongoing clinical trials investigating its potential benefits for various health conditions. Some notable areas of research include:

  • Its effects on inflammation and oxidative stress markers in COPD patients[8].
  • Potential benefits in reducing post-operative pain and inflammation following cesarean sections[5].
  • Its role in addressing accelerated aging in mental health disorders[6].
  • Potential anti-inflammatory and anti-senescence effects during coronary artery bypass graft surgery[9].
  • Its effectiveness in treating COVID-19 and reducing associated complications[10].

Potential Side Effects and Precautions

While quercetin is generally considered safe for most people when taken in appropriate doses, it’s important to be aware of potential side effects and precautions:

  • Common side effects may include headache, tingling sensations, or mild gastrointestinal discomfort.
  • Quercetin may interact with certain medications, including blood thinners and antibiotics. Always inform your healthcare provider about all supplements you’re taking.
  • High doses of quercetin may affect kidney function. Individuals with kidney problems should consult their doctor before using quercetin supplements.
  • Pregnant and breastfeeding women should avoid quercetin supplements due to limited safety data.

As with any supplement, it’s crucial to consult with a healthcare professional before adding quercetin to your regimen, especially if you have existing health conditions or are taking medications.

Condition Study Focus Quercetin Dosage Key Findings/Objectives
GERD Esophageal barrier function 500 mg twice daily Investigating effects on claudin-4 expression and esophageal barrier function
COPD Inflammation and oxidative stress 500-2000 mg daily Assessing reduction in inflammatory and oxidative stress markers
Coronary Artery Disease Vascular health markers 500 mg daily Examining effects on sirtuin-1 and sRAGE levels
Post-Cesarean Pain Acute post-operative pain 500 mg (single dose) Evaluating pain intensity and analgesic requirements
Mental Disorders & Aging Accelerated aging 1250 mg (with dasatinib) Investigating senolytic effects and changes in SASP
COVID-19 Treatment efficacy Varied (500-1000 mg daily) Assessing impact on disease progression and symptoms
Oral Lichen Planus Lesion treatment Not specified Evaluating effects on pain and lesion intensity

Ongoing Clinical Trials on Quercetin

  • Study on the Safety of Dasatinib and Quercetin for Patients with Mild Cognitive Impairment or Early Alzheimer’s Disease

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Study of Dasatinib and Quercetin combination for treating liver fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD)

    Not recruiting

    1 1
    The Netherlands

Glossary

  • Quercetin: A flavonoid and polyphenol found naturally in various plants and fruits, known for its antioxidant, anti-inflammatory, and antihistamine properties.
  • GERD: Gastroesophageal Reflux Disease, a condition where stomach acid frequently flows back into the esophagus.
  • COPD: Chronic Obstructive Pulmonary Disease, a group of lung diseases that cause airflow blockage and breathing-related problems.
  • Claudin-4: A protein involved in maintaining the barrier function of the esophageal lining.
  • Senolytic: A type of drug that selectively eliminates senescent cells, which are associated with aging and age-related diseases.
  • SASP: Senescence-Associated Secretory Phenotype, referring to the various factors secreted by senescent cells that can affect neighboring cells and tissues.
  • VAS: Visual Analog Scale, a measurement instrument used to assess subjective characteristics or attitudes that cannot be directly measured.
  • Sirtuin-1: A protein involved in cellular regulation that has been associated with longevity and protection against age-related diseases.
  • sRAGE: Soluble Receptor for Advanced Glycation End-products, a biomarker associated with various inflammatory conditions.
  • Oral Lichen Planus: A chronic inflammatory condition that affects mucous membranes inside the mouth.

References

  1. https://clinicaltrials.gov/study/NCT04851821
  2. https://clinicaltrials.gov/study/NCT03943459
  3. https://clinicaltrials.gov/study/NCT02226484
  4. https://clinicaltrials.gov/study/NCT03989271
  5. https://clinicaltrials.gov/study/NCT06650891
  6. https://clinicaltrials.gov/study/NCT05838560
  7. https://clinicaltrials.gov/study/NCT01375101
  8. https://clinicaltrials.gov/study/NCT06003270
  9. https://clinicaltrials.gov/study/NCT04907253
  10. https://clinicaltrials.gov/study/NCT04853199